Allogeneic FLT3 CAR T Cells with an Off-Switch Exhibit Potent Activity against AML and Can Be Depleted to Expedite Bone Marrow Recovery-Reference-Cited by-同舟云学术

Allogeneic FLT3 CAR T Cells with an Off-Switch Exhibit Potent Activity against AML and Can Be Depleted to Expedite Bone Marrow Recovery

Published:2020-10 Issue:10 Volume:28 Page:2237-2251
ISSN:1525-0016
Container-title:Molecular Therapy
language:en
Short-container-title:Molecular Therapy

Author:

Sommer Cesar,Cheng Hsin-Yuan,Nguyen Duy,Dettling Danielle,Yeung Yik Andy,Sutton Janette,Hamze Moustafa,Valton Julien,Smith Julianne,Djuretic Ivana,Chaparro-Riggers Javier,Sasu Barbra J.

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology,Genetics,Molecular Biology,Molecular Medicine

Reference50 articles.

1. Clinical significance of minimal residual disease in patients with acute leukaemia undergoing haematopoietic stem cell transplantation;Campana;Br. J. Haematol.,2013

2. Allogeneic hematopoietic cell transplantation for acute myeloid leukemia: time to move toward a minimal residual disease-based definition of complete remission?;Araki;J. Clin. Oncol.,2016

3. Axicabtagene ciloleucel CAR T-cell therapy in refractory large B-cell lymphoma;Neelapu;N. Engl. J. Med.,2017

4. Tisagenlecleucel in children and young adults with B-cell lymphoblastic leukemia;Maude;N. Engl. J. Med.,2018

5. Anti-BCMA CAR T-cell therapy bb2121 in relapsed or refractory multiple myeloma;Raje;N. Engl. J. Med.,2019

Cited by 59 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent updates on allogeneic CAR-T cells in hematological malignancies;Cancer Cell International;2024-09-03

2. T cell-redirecting therapies in hematological malignancies: Current developments and novel strategies for improved targeting;Molecular Therapy;2024-09

3. Cell-Based Treatment in Acute Myeloid Leukemia Relapsed after Allogeneic Stem Cell Transplantation;Biomedicines;2024-08-01

4. FLT3-Mutated Leukemic Stem Cells: Mechanisms of Resistance and New Therapeutic Targets;Cancers;2024-05-10

5. Precision off-the-shelf natural killer cell therapies for oncology with logic-gated gene circuits;Cell Reports;2024-05